Terms: = Brain cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
418 results:
1. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Omics Pan-cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
Huang R; Kong Y; Luo Z; Li Q
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
[TBL] [Abstract] [Full Text] [Related]
4. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
5. EMX2 inhibits clear cell renal cell carcinoma progress via modulating akt/FOXO3a pathway.
Zhou X; Dong S; Zhou Y; He Z; Zhang Z; Liao L; Zou B; Zheng X; Peng K; Duan X
Mol Carcinog; 2024 May; 63(5):951-961. PubMed ID: 38362840
[TBL] [Abstract] [Full Text] [Related]
6. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
7. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
Nie J; Dang S; Zhu R; Lu T; Zhang W
Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
[TBL] [Abstract] [Full Text] [Related]
8. Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma.
Shaikh MAJ; Altamimi ASA; Afzal M; Gupta G; Singla N; Gilhotra R; Almalki WH; Kazmi I; Alzarea SI; Prasher P; Singh SK; Dua K
Pathol Res Pract; 2024 Feb; 254():155121. PubMed ID: 38262269
[TBL] [Abstract] [Full Text] [Related]
9. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract] [Full Text] [Related]
10. STEAP3 is a prognostic biomarker that promotes glioma progression by regulating immune microenvironment and PI3K-akt pathway.
Song Z; Zhao Z; Zhu S; Jin Q; Shi Y; Zhang S; Wang Z; Wang Y; Zhao Z
Cancer Biomark; 2023; 38(4):505-522. PubMed ID: 37980651
[TBL] [Abstract] [Full Text] [Related]
11. Protein Disulfide Isomerase A2 Is Correlated with Immune Infiltrates and Is a Novel Prognostic Biomarker in Glioma Patients.
Ma ZG; Liu YX; Zou N; Huang Z; Wang M; Li T; Zhou J; Chen LG
Curr Med Sci; 2023 Dec; 43(6):1107-1115. PubMed ID: 37978154
[TBL] [Abstract] [Full Text] [Related]
12. Targeting the SPHK1/S1P/S1PR2 axis ameliorates GH-secreted pituitary adenoma progression.
Sun H; Hu B; Wu C; Jiang T
Eur J Clin Invest; 2024 Mar; 54(3):e14117. PubMed ID: 37888843
[TBL] [Abstract] [Full Text] [Related]
13. Multiomics and bioinformatics identify differentially expressed effectors in the brain of
Yuan H; Jiang T; Zhang WD; Yang Z; Luo S; Wang X; Zhu X; Qi S; Mahmmod YS; Zhang XX; Yuan ZG
Front Cell Infect Microbiol; 2023; 13():1267629. PubMed ID: 37818043
[TBL] [Abstract] [Full Text] [Related]
14. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
15. PHLPP2: A Prognostic Biomarker in Adenocarcinoma of the Rectum.
Xie K
Turk J Gastroenterol; 2023 Oct; 34(10):1099-1106. PubMed ID: 37737218
[TBL] [Abstract] [Full Text] [Related]
16. Glioblastoma cellular MAP4K1 facilitates tumor growth and disrupts T effector cell infiltration.
Sun JM; Fan HY; Zhu Y; Pan TT; Wu YP; Zhang DY; Hou XY
Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37734869
[TBL] [Abstract] [Full Text] [Related]
17. Toward Precision Oncology in Glioblastoma with a Personalized cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
[TBL] [Abstract] [Full Text] [Related]
18. CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting akt1 expression.
Jin Z; Zhao L; Chang Y; Jin R; Hu F; Wu S; Xue Z; Ma Y; Chen C; Zheng M; Chang Y; Jin H; Xie Q; Huang C; Huang H
Cell Death Dis; 2023 Aug; 14(8):563. PubMed ID: 37633993
[TBL] [Abstract] [Full Text] [Related]
19. RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-akt-mTOR pathway.
Liang L; Zhao Z; Jin Q; Zhang S; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):80-86. PubMed ID: 37571896
[TBL] [Abstract] [Full Text] [Related]
20. PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.
Otani R; Ikegami M; Yamada R; Yajima H; Kawamura S; Shimizu S; Tanaka S; Takayanagi S; Takami H; Yamaguchi T
J Neurooncol; 2023 Aug; 164(1):221-229. PubMed ID: 37552362
[TBL] [Abstract] [Full Text] [Related]
[Next]